Sector

Materials

51 companies under coverage across 13 industries.

Industries

Browse by industry

Aluminum 1 Commodity Chemicals 1 Construction Materials 5 Copper 1 Diversified Chemicals 3 Fertilizers & Agricultural Chemicals 4 Gold 3 Industrial Gases 2 Metal, Glass & Plastic Containers 4 Paper & Plastic Packaging Products & Materials 8 Silver 1 Specialty Chemicals 13 Steel 5

Coverage

Materials companies

Equity Research

Olin Corporation (OLN)

BUY. 12-month probability-weighted target $24 (+35% vs spot). Gross Margin explains 49% of Monte Carlo outcome variance.

OLNEquity ResearchMonte Carlo

9 September 2026Rating: BUY · +37.8%

Equity Research

Scotts Miracle-Gro Company (SMG)

BUY. 12-month probability-weighted target $68 (+19% vs spot). Gross Margin explains 50% of Monte Carlo outcome variance.

SMGEquity ResearchMonte Carlo

9 September 2026Rating: BUY · +14.5%

Equity Research

Silgan Holdings Inc (SLGN)

HOLD. 12-month probability-weighted target $45 (+13% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

SLGNEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +9.4%

Equity Research

Graphic Packaging Holding Company (GPK)

HOLD. 12-month probability-weighted target $11 (+10% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

GPKEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +7.1%

Equity Research

Sonoco Products Company (SON)

HOLD. 12-month probability-weighted target $54 (+8% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

SONEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +4.4%

Equity Research

CRH PLC ADR (CRH)

BUY. 12-month probability-weighted target $113 (+25% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

CRHEquity ResearchMonte Carlo

9 September 2026Rating: BUY · +0.6%

Equity Research

Vulcan Materials Company (VMC)

HOLD. 12-month probability-weighted target $308 (+19% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

VMCEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -0.8%

Equity Research

Linde plc Ordinary Shares (LIN)

HOLD. 12-month probability-weighted target $523 (+12% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

LINEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -0.9%

Equity Research

Martin Marietta Materials Inc (MLM)

HOLD. 12-month probability-weighted target $616 (+20% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

MLMEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -2.0%

Equity Research

Smurfit WestRock plc (SW)

HOLD. 12-month probability-weighted target $45 (+1% vs spot). Gross Margin explains 86% of Monte Carlo outcome variance.

SWEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -2.4%

Equity Research

Cabot Corporation (CBT)

HOLD. 12-month probability-weighted target $92 (+15% vs spot). P/E Multiple explains 54% of Monte Carlo outcome variance.

CBTEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -3.5%

Equity Research

Albemarle Corp (ALB)

HOLD. 12-month probability-weighted target $141 (+8% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

ALBEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -3.8%

Equity Research

Crown Holdings Inc (CCK)

HOLD. 12-month probability-weighted target $116 (+3% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

CCKEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -4.4%

Equity Research

Dow Inc (DOW)

HOLD. 12-month probability-weighted target $29 (-2% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

DOWEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -4.6%

Equity Research

Ball Corporation (BALL)

HOLD. 12-month probability-weighted target $60 (-2% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

BALLEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -5.2%

Equity Research

Royal Gold Inc (RGLD)

HOLD. 12-month probability-weighted target $318 (+22% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

RGLDEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -6.1%

Equity Research

Alcoa Corp (AA)

HOLD. 12-month probability-weighted target $49 (-5% vs spot). P/E Multiple explains 47% of Monte Carlo outcome variance.

AAEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -6.7%

Equity Research

Eagle Materials Inc (EXP)

HOLD. 12-month probability-weighted target $206 (+8% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

EXPEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -6.8%

Equity Research

Knife River Corporation (KNF)

HOLD. 12-month probability-weighted target $79 (+28% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

KNFEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -7.3%

Equity Research

International Paper (IP)

HOLD. 12-month probability-weighted target $35 (-4% vs spot). Gross Margin explains 88% of Monte Carlo outcome variance.

IPEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -7.5%

Equity Research

Air Products and Chemicals Inc (APD)

HOLD. 12-month probability-weighted target $284 (-5% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

APDEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -7.7%

Equity Research

Steel Dynamics Inc (STLD)

HOLD. 12-month probability-weighted target $260 (+8% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

STLDEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -7.9%

Equity Research

PPG Industries Inc (PPG)

HOLD. 12-month probability-weighted target $118 (+7% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

PPGEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -8.2%

Equity Research

Amcor PLC (AMCR)

HOLD. 12-month probability-weighted target $41 (-7% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

AMCREquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -10.6%

Equity Research

Dupont De Nemours Inc (DD)

HOLD. 12-month probability-weighted target $135 (+3% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

DDEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -10.7%

Equity Research

Packaging Corp of America (PKG)

HOLD. 12-month probability-weighted target $244 (+5% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

PKGEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -10.8%

Equity Research

AptarGroup Inc (ATR)

HOLD. 12-month probability-weighted target $128 (+3% vs spot). P/E Multiple explains 51% of Monte Carlo outcome variance.

ATREquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -11.3%

Equity Research

Nucor Corp (NUE)

HOLD. 12-month probability-weighted target $256 (+0% vs spot). P/E Multiple explains 46% of Monte Carlo outcome variance.

NUEEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -13.3%

Equity Research

Corteva Inc (CTVA)

HOLD. 12-month probability-weighted target $79 (-8% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

CTVAEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -13.4%

Equity Research

Sherwin-Williams Co (SHW)

HOLD. 12-month probability-weighted target $336 (+3% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

SHWEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -14.1%

Equity Research

Greif Bros Corporation (GEF)

HOLD. 12-month probability-weighted target $81 (-4% vs spot). Gross Margin explains 53% of Monte Carlo outcome variance.

GEFEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -14.3%

Equity Research

RPM International Inc (RPM)

HOLD. 12-month probability-weighted target $103 (+1% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

RPMEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -14.6%

Equity Research

Cleveland-Cliffs Inc (CLF)

SELL. 12-month probability-weighted target $10 (-19% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

CLFEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -15.2%

Equity Research

Ecolab Inc (ECL)

HOLD. 12-month probability-weighted target $277 (+0% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

ECLEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -15.5%

Equity Research

Newmont Corporation (NEM)

SELL. 12-month probability-weighted target $106 (-17% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

NEMEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -15.7%

Equity Research

Axalta Coating Systems Ltd (AXTA)

HOLD. 12-month probability-weighted target $36 (+2% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

AXTAEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -16.0%

Equity Research

Avient Corp (AVNT)

HOLD. 12-month probability-weighted target $42 (+0% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

AVNTEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -20.6%

Equity Research

NewMarket Corporation (NEU)

SELL. 12-month probability-weighted target $796 (-8% vs spot). Gross Margin explains 53% of Monte Carlo outcome variance.

NEUEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -20.7%

Equity Research

Coeur Mining Inc (CDE)

SELL. 12-month probability-weighted target $16 (-21% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

CDEEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -21.2%

Equity Research

Avery Dennison Corp (AVY)

HOLD. 12-month probability-weighted target $162 (-5% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

AVYEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -23.4%

Equity Research

Westlake Chemical Corporation (WLK)

HOLD. 12-month probability-weighted target $78 (+4% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

WLKEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -23.9%

Equity Research

Solstice Advanced Materials, Inc (SOLS)

SELL. 12-month probability-weighted target $57 (-12% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

SOLSEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -26.4%

Equity Research

Commercial Metals Company (CMC)

HOLD. 12-month probability-weighted target $67 (-5% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

CMCEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -27.6%

Equity Research

International Flavors & Fragrances Inc (IFF)

SELL. 12-month probability-weighted target $75 (-12% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

IFFEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -28.7%

Equity Research

Freeport-McMoran Copper & Gold Inc (FCX)

SELL. 12-month probability-weighted target $66 (-14% vs spot). P/E Multiple explains 59% of Monte Carlo outcome variance.

FCXEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -31.8%

Equity Research

The Mosaic Company (MOS)

SELL. 12-month probability-weighted target $18 (-31% vs spot). Gross Margin explains 85% of Monte Carlo outcome variance.

MOSEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -35.0%

Equity Research

Reliance Steel & Aluminum Co (RS)

SELL. 12-month probability-weighted target $312 (-22% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

RSEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -35.2%

Equity Research

LyondellBasell Industries NV (LYB)

SELL. 12-month probability-weighted target $58 (-10% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

LYBEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -35.4%

Equity Research

Ashland Global Holdings Inc (ASH)

SELL. 12-month probability-weighted target $63 (-13% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

ASHEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -35.7%

Equity Research

Hecla Mining Company (HL)

SELL. 12-month probability-weighted target $14 (-31% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

HLEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -36.6%

Equity Research

CF Industries Holdings Inc (CF)

SELL. 12-month probability-weighted target $72 (-46% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

CFEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -45.9%